Aerovate Therapeutics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 7, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	91,372	37,113	22,555	-	-
Market Cap Growth	64.54%	64.54%	-	-	-
Enterprise Value	88,241	34,054	20,931	-	-
Last Close Price	399.80	163.30	102.90	-	-
PS Ratio	44.42	18.04	13.29	-	-
PB Ratio	25.95	10.54	8.79	-	-
P/TBV Ratio	25.97	10.55	8.79	-	-
P/OCF Ratio	-	-	343.75	-	-
EV/Sales Ratio	42.90	16.55	12.33	-	-
Debt / Equity Ratio	0.04	0.04	0.03	-0.93	-0.90
Asset Turnover	0.50	0.50	0.68	0.89	-
Inventory Turnover	7.60	7.60	13.51	5.36	-
Quick Ratio	4.09	4.09	2.35	0.05	0.04
Current Ratio	4.31	4.31	2.53	0.08	0.09
Return on Equity (ROE)	-9.46%	-9.46%	-	-	-
Return on Assets (ROA)	-3.41%	-3.41%	-12.60%	-27.27%	-
Return on Capital (ROIC)	-4.55%	-4.55%	-26.04%	-	-
Earnings Yield	-0.31%	-0.77%	-2.80%	-	-
FCF Yield	-0.59%	-1.45%	-0.10%	-	-
Buyback Yield / Dilution	-20.70%	-20.70%	-92.24%	-3.31%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.